Insider · CIK 0001648835
Eugenia Corrales
director
Files at VIAV (VIAVI SOLUTIONS INC.). First filing Dec 11, 2025, latest Dec 11, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $63k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VIAV: VIAVI SOLUTIONS INC.
VIAVOct 9, 2026 · close 45.46
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | VIAVI SOLUTIONS INC. | $63k 3,384 shares | -50% | +114% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | VIAV VIAVI SOLUTIONS INC. | SOpen-market sale Common Stock10b5-1 | -3,384 | $18.76 | $63k | 3,384 | Dec 11, 2025 |
| Nov 13, 2025 | VIAV VIAVI SOLUTIONS INC. | AGrant or award Restricted Stock Unitderivative | +14,369 | $0.00 | $0 | 14,369 | Nov 13, 2025 |
| Nov 7, 2025 | VIAV VIAVI SOLUTIONS INC. | MOption exercise Common Stock | +6,768 | $0.00 | $0 | 6,768 | Nov 10, 2025 |
| Nov 7, 2025 | VIAV VIAVI SOLUTIONS INC. | MOption exercise Restricted Stock Unitderivative | -6,768 | $0.00 | $0 | 0 | Nov 10, 2025 |
| Aug 28, 2025 | VIAV VIAVI SOLUTIONS INC. | AGrant or award Restricted Stock Unitderivative | +6,768 | $0.00 | $0 | 6,768 | Aug 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.